Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "clinical"

3747 News Found

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
Hospitals | June 23, 2026

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego
Biotech | June 23, 2026

Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego

The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players


Teva closes $700M Emalex acquisition
News | June 23, 2026

Teva closes $700M Emalex acquisition

Bolstering neuroscience push with late-stage Tourette therapy


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
Biopharma | June 22, 2026

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges


Nearly half of cardiac investigations in men above 30 show abnormalities, claims report
Healthcare | June 22, 2026

Nearly half of cardiac investigations in men above 30 show abnormalities, claims report

Study of 78,000 diagnostic investigations by Mahajan Imaging identifies over 13,000 abnormal or critical findings, highlighting silent health risks among working-age men


Evonik sells Hanau pharma assets to ProChem in strategic portfolio shift
News | June 21, 2026

Evonik sells Hanau pharma assets to ProChem in strategic portfolio shift

The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas